$7.34 -0.06 (%) Sunesis Pharmaceuticals Inc - NASDAQ

Sep. 19, 2014 | 04:00 PM

Partner Headlines

  1. Morning Market Losers

    Benzinga | Aug. 29, 2014 | 09:52AM EST
  2. Benzinga's Top Downgrades

    Benzinga | Aug. 29, 2014 | 09:15AM EST
  3. Wedbush Downgrades Sunesis Pharmaceuticals To Neutral, Shares Drop

    Benzinga | Aug. 29, 2014 | 08:31AM EST
  4. UBS Says Sunesis Leukemia Pivotal Trial Success 'Likely'

    Benzinga | Aug. 27, 2014 | 16:05PM EST
  5. Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation Plan for Qinprezo For AML

    Benzinga | Jul. 9, 2014 | 07:04AM EST
  6. Events Scheduled for Week of Jun. 16th to Jun. 20th

    Benzinga | Jun. 17, 2014 | 10:48AM EST
  7. Sunesis Announces Data of Ongoing Vosaroxin Study at ASCO

    Benzinga | Apr. 22, 2014 | 07:09AM EST
  8. Mid-Morning Market Update: Markets Drop; Family Dollar Plans To Close 370 Stores

    Benzinga | Apr. 10, 2014 | 10:27AM EST
  9. Sunesis Pharmaceuticals Announces Global Licenses for Two Kinase Inhibitor Programs

    Benzinga | Jan. 9, 2014 | 07:06AM EST
  10. Sunesis Pharmaceuticals Announces Investigator-Sponsored Phase I/II Trial Evaluating Vosaroxin in Myelodysplastic Syndrome

    Benzinga | Oct. 28, 2013 | 07:07AM EST
  11. Sunesis Pharmaceuticals Announces Closing of $40 Million in Previously Announced Royalty and Debt Financings

    Benzinga | Sep. 20, 2012 | 01:04AM EST
  12. Stocks Hitting 52-Week Highs

    Benzinga | Sep. 11, 2012 | 04:03AM EST
  13. Morning Market Movers

    Benzinga | Sep. 11, 2012 | 03:48AM EST
  14. From Earlier: Sunesis Pharmaceuticals to Implement One-Time Sample Size Increase to Phase 3 VALOR Trial in AML

    Benzinga | Sep. 11, 2012 | 02:21AM EST
  15. Cantor Fitzgerald Reiterates Buy Rating, $6 PT for Sunesis Pharmaceuticals

    Benzinga | Jun. 15, 2012 | 04:42AM EST
  16. Benzinga's Microcap Movers for Monday March 5, 2012

    Benzinga | Mar. 5, 2012 | 15:18PM EST
Trading Center